Inside STAT: How will voters grade Trump on drug pricing initiatives?

During the 2016 campaign, President Trump positioned himself as a foe of the pharmaceutical industry, rejecting their donations and promising to let Medicare negotiate drug prices. As his 2020 campaign ramps up, it’s a different story. At a recent rally in Manchester, N.H., Trump barely mentioned drug prices. His supporters don’t seem to be paying much attention either. Despite polling that shows that drug pricing is a top priority for voters, many attendees weren’t aware of what the administration has proposed in Trump’s first term — and the struggles it's had implementing the plans. STAT’s Nicholas Florko has the story from Manchester.